Revance Company Insiders
RVNC Stock | USD 3.40 0.11 3.34% |
About 91 percent of Revance's insiders are activelly selling. The analysis of insiders' sentiment of trading Revance stock suggests that quite a large number of insiders are panicking at this time. Revance employs about 597 people. The company is managed by 40 executives with a total tenure of roughly 207 years, averaging almost 5.0 years of service per executive, having 14.93 employees per reported executive.
Mark Foley CEO CEO Director |
Dan Browne CEO Co-Founder and Presidentident, CEO, Board Member |
Revance's Insider Buying Vs Selling
9
Selling | Buying |
Latest Trades
2024-04-16 | Erica Jordan | Disposed 2392 @ 3.8 | View | ||
2024-03-18 | Tobin Schilke | Disposed 9361 @ 5.04 | View | ||
2023-10-04 | Thomas R. Carper | Acquired @ 10.55 | |||
2023-09-05 | Dwight Moxie | Disposed 23853 @ 17.81 | View | ||
2023-08-03 | Mark J Foley | Disposed 26279 @ 22.57 | View | ||
2023-07-03 | Mark J Foley | Disposed 26279 @ 24.94 | View | ||
2023-06-15 | Carey Oconnor Kolaja | Disposed 2500 @ 28.24 | View | ||
2023-06-09 | Dustin S Sjuts | Disposed 5000 @ 30.82 | View | ||
2023-06-01 | Tobin Schilke | Disposed 2701 @ 30.57 | View | ||
2023-05-15 | Mark J Foley | Disposed 70447 @ 34.55 | View | ||
2023-05-01 | Tobin Schilke | Disposed 3201 @ 31.7 | View |
Monitoring Revance's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Revance's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Revance. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Revance's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Revance |
Revance's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Revance's future performance. Based on our forecasts, it is anticipated that Revance will maintain a workforce of about 600 employees by May 2024.Revance's latest congressional trading
Congressional trading in companies like Revance, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Revance by those in governmental positions are based on the same information available to the general public.
2023-10-04 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Revance Management Team Effectiveness
The company has return on total asset (ROA) of (0.2602) % which means that it has lost $0.2602 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.9678) %, meaning that it created substantial loss on money invested by shareholders. Revance's management efficiency ratios could be used to measure how well Revance manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 2.24, whereas Return On Tangible Assets are forecasted to decline to (0.73). At present, Revance's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 11.7 M, whereas Total Assets are forecasted to decline to about 331.9 M.The current year's Common Stock Shares Outstanding is expected to grow to about 88.8 M, whereas Net Loss is projected to grow to (304.7 M).
Revance Workforce Comparison
Revance is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 4,641. Revance retains roughly 597 in number of employees claiming about 13% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.73) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.73. Revance Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Revance insiders, such as employees or executives, is commonly permitted as long as it does not rely on Revance's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Revance insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.9091 | 10 | 11 | 1,692,119 | 106,957 |
2023-12-01 | 3.0 | 3 | 1 | 962.00 | 4,712 |
2023-09-01 | 0.4444 | 4 | 9 | 186,729 | 166,884 |
2023-06-01 | 1.5 | 18 | 12 | 63,538 | 185,146 |
2023-03-01 | 0.3125 | 5 | 16 | 151,235 | 164,242 |
2022-12-01 | 1.0 | 3 | 3 | 1,855 | 53,747 |
2022-03-01 | 0.6667 | 8 | 12 | 649,298 | 25,012 |
2021-12-01 | 1.6667 | 5 | 3 | 112,724 | 44,165 |
2021-06-01 | 8.5 | 17 | 2 | 63,914 | 413.00 |
2021-03-01 | 1.6 | 16 | 10 | 428,088 | 80,388 |
2020-12-01 | 0.3333 | 2 | 6 | 841.00 | 167,581 |
2020-09-01 | 1.8571 | 13 | 7 | 2,067,631 | 199,503 |
2020-06-01 | 16.0 | 16 | 1 | 127,763 | 432.00 |
2020-03-01 | 1.5 | 9 | 6 | 800,500 | 10,848 |
2019-12-01 | 0.5556 | 5 | 9 | 941,268 | 73,103 |
2019-06-01 | 17.0 | 17 | 1 | 110,923 | 1,383 |
2019-03-01 | 0.8 | 12 | 15 | 448,191 | 36,887 |
2018-12-01 | 0.8333 | 5 | 6 | 121,381 | 16,479 |
2018-06-01 | 4.5 | 18 | 4 | 190,811 | 18,062 |
2018-03-01 | 1.0556 | 19 | 18 | 505,841 | 124,101 |
2017-12-01 | 0.8571 | 6 | 7 | 48,076 | 67,161 |
2017-09-01 | 1.6667 | 5 | 3 | 148,331 | 30,731 |
2017-06-01 | 2.8333 | 17 | 6 | 91,904 | 70,093 |
2017-03-01 | 1.0 | 6 | 6 | 342,900 | 28,540 |
2016-12-01 | 0.4 | 2 | 5 | 37,000 | 39,229 |
2016-09-01 | 2.0 | 2 | 1 | 18,666 | 666.00 |
2016-06-01 | 1.2222 | 11 | 9 | 59,749 | 21,123 |
2016-03-01 | 1.1818 | 13 | 11 | 353,998 | 30,158 |
2015-12-01 | 0.625 | 5 | 8 | 253,271 | 21,796 |
2015-09-01 | 0.2727 | 3 | 11 | 6,000 | 15,699 |
2015-06-01 | 1.0526 | 20 | 19 | 106,133 | 35,219 |
2015-03-01 | 1.2667 | 19 | 15 | 480,623 | 10,000 |
2014-12-01 | 0.7273 | 8 | 11 | 11,480 | 9,000 |
2014-09-01 | 0.5263 | 10 | 19 | 233,374 | 195,587 |
2014-03-01 | 0.6271 | 37 | 59 | 18,778,675 | 11,576,473 |
Revance Notable Stakeholders
A Revance stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Revance often face trade-offs trying to please all of them. Revance's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Revance's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Foley | CEO Director | Profile | |
Dan Browne | Co-Founder and Presidentident, CEO, Board Member | Profile | |
Daniel Browne | Co-Founder and Presidentident, CEO, Director | Profile | |
Angus Russell | Chairman of the Board | Profile | |
Ben Putman | Vice President - Digital | Profile | |
Caryn McDowell | Senior Vice President General Counsel, and Corporate Secretary | Profile | |
Lauren Silvernail | CFO, Executive Vice President of Corporate Development | Profile | |
Sharon Hall | Vice President of Regulatory Affairs | Profile | |
Todd Zavodnick | Chief Commercial Officer and President Aesthetics & Therapeutics | Profile | |
Erica Bazerkanian | Vice President of Marketing | Profile | |
Dustin Sjuts | Vice President of Strategy and Sales | Profile | |
Taryn Conway | Vice President of Marketing | Profile | |
Tobin Schilke | CFO and Principal Financial Officer | Profile | |
Abhay Joshi | COO | Profile | |
Curtis Ruegg | Executive VP of RandD and Technical Operations | Profile | |
Jill Beraud | Director | Profile | |
Jeanie Herbert | Sr. Director of Investor Relations | Profile | |
Philip Vickers | Independent Director | Profile | |
Julian Gangolli | Director | Profile | |
Robert Byrnes | Independent Director | Profile | |
Ron Wooten | Independent Director | Profile | |
Phil Vickers | Director | Profile | |
Ronald Wooten | Independent Director | Profile | |
Marc Korenberg | Senior Director - Commercial Operations | Profile | |
Mark Prygocki | Director | Profile | |
Chris Nolet | Director | Profile | |
Cyril Allouche | Principal Financial Officer and Principal Accounting Officer | Profile | |
Phyllis Gardner | Board Member | Profile | |
Jonathan Tunnicliffe | Board Member | Profile | |
Erica Jordan | Chief Officer | Profile | |
Dwight Moxie | Chief Counsel | Profile | |
Justin Ford | VP People | Profile | |
Jim Glasheen | Board Member | Profile | |
Jessica Serra | Head ESG | Profile | |
Ronald Eastman | Board Member | Profile | |
Aubrey Rankin | Consultant | Profile | |
Conor Gallagher | Head Aesthetics | Profile | |
Azita Nejad | VP Operations | Profile | |
Amie Krause | Chief Officer | Profile | |
MD MBA | Chief Officer | Profile |
About Revance Management Performance
The success or failure of an entity such as Revance often depends on how effective the management is. Revance management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Revance management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Revance management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.69) | (0.73) | |
Return On Capital Employed | (0.57) | (0.60) | |
Return On Assets | (0.68) | (0.71) | |
Return On Equity | 2.14 | 2.24 |
The data published in Revance's official financial statements usually reflect Revance's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Revance. For example, before you start analyzing numbers published by Revance accountants, it's critical to develop an understanding of what Revance's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Revance's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Revance's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Revance's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Revance. Please utilize our Beneish M Score to check the likelihood of Revance's management manipulating its earnings.
Revance Workforce Analysis
Traditionally, organizations such as Revance use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Revance within its industry.Revance Manpower Efficiency
Return on Revance Manpower
Revenue Per Employee | 392K | |
Revenue Per Executive | 5.9M | |
Net Loss Per Employee | 542.7K | |
Net Loss Per Executive | 8.1M | |
Working Capital Per Employee | 418.2K | |
Working Capital Per Executive | 6.2M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Revance Stock analysis
When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Revance's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.83) | Revenue Per Share 2.766 | Quarterly Revenue Growth 0.398 | Return On Assets (0.26) | Return On Equity (20.97) |
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.